Evidence map›Paper›PMID 35454955›Full record

ArticleCancers2022

Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.

Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, Gil M Lewitus, Lanuel Oz-Ari, Ayellet Jehassi, Avivit Peer, Ilit Turgeman, Olga Vernicova, Paula Berman and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Cannabis use among recently treated cancer patients: perceptions and experiences.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Gil Bar-SelaCancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, Afula 1834111, Israel.
Idan CohenCancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, Afula 1834111, Israel.ORCID 0000-0001-6933-9385
Salvatore Campisi-PintoThe Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa 320003, Israel.
Gil M LewitusThe Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa 320003, Israel.ORCID 0000-0001-8696-8677
Lanuel Oz-AriBruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 320002, Israel.
Ayellet JehassiStatistic Unit, Emek Medical Center, Afula 1834111, Israel.
Avivit PeerDivision of Oncology, Rambam Health Care Campus, Haifa 320002, Israel.
Ilit TurgemanDivision of Oncology, Rambam Health Care Campus, Haifa 320002, Israel.ORCID 0000-0003-4123-1107
Olga VernicovaCancer Center, Emek Medical Center, 21 Yitzhak Rabin Blvd, Afula 1834111, Israel.
Paula BermanThe Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa 320003, Israel.ORCID 0000-0002-6821-3307
Mira WollnerDivision of Oncology, Rambam Health Care Campus, Haifa 320002, Israel.
Mor MoskovitzDivision of Oncology, Rambam Health Care Campus, Haifa 320002, Israel.
David MeiriThe Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, Technion-Israel Institute of Technology, Haifa 320003, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original article [...].

Identifiers

PMID35454955
PMCPMC9031888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.